Upload
gordon-mitchell
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
‘One size will not fit all’Differences between medical devices and pharmaceuticals: Consequences for the practice of HTA
Chantale Lessard, BPharm, MSc, PhD, DcomplDDirector, Health Economics, Policy & Reimbursement, Medical Affairs, Covidien, MedtronicLecturer, Department of Health Administration, School of Public Health, University of Montreal
CADTH Symposium 2015, Panel Session – Valuing Medical Technologies
2 | Medtronic Confidential
Main differences between medical devices and pharmaceuticals impacting on HTA
3 | Medtronic Confidential
Main differences between medical devices and pharmaceuticals impacting on HTA
4 | Medtronic Confidential
Main differences between medical devices and pharmaceuticals impacting on HTA
5 | Medtronic Confidential
Main differences between medical devices and pharmaceuticals impacting on HTA
6 | Medtronic Confidential
Consequences for the practice of HTA
• Recognition that a ‘one-size-fits-all’ approach to evaluation is inappropriate
• Evaluation approach should be tailored to the medical device• Based on the type, context of practice, indication, and use
• View the HTA for medical devices as an iterative process• Information about clinical efficacy and cost-effectiveness
is necessary but not sufficient– Understanding the social, ethical, professional and
organizational implications is also vital
• Development of innovative HTA methods for medical devices will require the engagement of industry, and of decision- and policy-makers
7 | Medtronic Confidential
Contact
Chantale Lessard, BPharm, MSc, PhD, DcomplD Director, Health Economics, Policy & ReimbursementMedical Affairs, Covidien
Medtronic8455, route TranscanadienneVille St-Laurent, Québec, H4S 1Z1